Darrin Baines is a British health economist whose work centres on pharmacy practice, drug costs, economic evaluation, health systems, NHS productivity and the validation of health-economic models. Over a career spanning more than three decades, he has worked across academic research, public-sector economics, professional training, senior industry consultancy and independent methodological development.

Earlier in his career, as a senior lecturer at the University of Birmingham, he was founding director of the MSc in Health Economics and Health Policy. His early research contributed to the use of ASTRO-PU weighted prescribing units for comparing general-practice prescribing costs more fairly across patient populations, and examined prescribing budgets as a means of controlling those costs.

He later held professorial appointments in health economics at Coventry University and Bournemouth University, and led the UK side of British Council-supported health economics partnerships with China and Egypt. He subsequently headed health economics teams at OPEN Health and Clarivate.

His later work has focused on decision-analytic modelling, health technology assessment, model verification and Markov-chain robustness, including published work in Value in Health and Social Science and Medicine. He holds a PhD in Health Economics from the University of Nottingham, an MSc in Health Economics from the University of York and an MSc in Health Care Ethics from the University of Birmingham.

He now works through Intelligent Parameters, applying AI, formal modelling, semantic methods and validation frameworks to health-economic analysis, model review and decision-ready evidence.

AT A GLANCE

Nationality

United Kingdom

PhD

Health Economics, University of Nottingham, 1999

MSc

Health Economics, University of York, 1994

MSc

Health Care Ethics, University of Birmingham, 2000

BA (Hons)

Economics, University of York, 1992

Key activities

1990s

Prescribing economics and NHS fundholding

Research on general-practice prescribing, prescribing budgets, GP fundholding and methods for comparing prescribing expenditure fairly across patient populations.

2000s

Community pharmacy, policy and professional change

Professional and academic work on pharmacy economics, community pharmacy services, pharmaceutical policy and the changing role of pharmacists in the NHS.

2010s

Health systems, productivity and economic evaluation

Work on health-system reform, community pharmacy productivity, health-services research and the economic evaluation of healthcare interventions.

2020s

HTA modelling, model verification and semantic health economics

Current work on cost-effectiveness modelling, model verification, semantic health economics and computational tools for health-economic analysis.